These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 25469032)
1. Advances in non-surgical management of primary liver cancer. Chen X; Liu HP; Li M; Qiao L World J Gastroenterol; 2014 Nov; 20(44):16630-8. PubMed ID: 25469032 [TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system. Han K; Kim JH World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959 [TBL] [Abstract][Full Text] [Related]
3. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment. Yegin EG; Oymaci E; Karatay E; Coker A Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100 [TBL] [Abstract][Full Text] [Related]
4. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions. Zhu J; Yin T; Xu Y; Lu XJ J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100 [TBL] [Abstract][Full Text] [Related]
5. Management of Hepatocellular Carcinoma: Current Status and Future Directions. Au JS; Frenette CT Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in the management of hepatocellular carcinoma. Zhang S; Yue M; Shu R; Cheng H; Hu P J BUON; 2016; 21(2):307-11. PubMed ID: 27273938 [TBL] [Abstract][Full Text] [Related]
7. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma. Yin X; Zhang L; Wang YH; Zhang BH; Gan YH; Ge NL; Chen Y; Li LX; Ren ZG BMC Cancer; 2014 Nov; 14():849. PubMed ID: 25409554 [TBL] [Abstract][Full Text] [Related]
8. Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions. Inchingolo R; Posa A; Mariappan M; Spiliopoulos S World J Gastroenterol; 2019 Aug; 25(32):4614-4628. PubMed ID: 31528090 [TBL] [Abstract][Full Text] [Related]
9. Nonsurgical treatment of hepatocellular carcinoma. Llovet JM; Sala M; Bruix J Liver Transpl; 2000 Nov; 6(6 Suppl 2):S11-5. PubMed ID: 11084079 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma. Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662 [TBL] [Abstract][Full Text] [Related]
11. The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years? Yim SY; Seo YS; Jung CH; Kim TH; Lee JM; Kim ES; Keum B; Jong YK; An H; Kim JH; Yim HJ; Kim DS; Jeen YT; Yeon JE; Lee HS; Chun HJ; Byun KS; Um SH; Kim CD; Ryu HS Liver Int; 2016 Mar; 36(3):445-53. PubMed ID: 26352789 [TBL] [Abstract][Full Text] [Related]
12. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort. Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438 [TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation for hepatocellular carcinoma. Nishikawa H; Kimura T; Kita R; Osaki Y Int J Hyperthermia; 2013 Sep; 29(6):558-68. PubMed ID: 23937321 [TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma. Peng ZW; Chen MS Oncology; 2013; 84 Suppl 1():40-3. PubMed ID: 23428857 [TBL] [Abstract][Full Text] [Related]
15. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation. Ginsburg M; Zivin SP; Wroblewski K; Doshi T; Vasnani RJ; Van Ha TG J Vasc Interv Radiol; 2015 Mar; 26(3):330-41. PubMed ID: 25534635 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy for hepatocellular carcinoma: current situation and prospect. Wang Z; Zhang G; Wu J; Jia M Drug Discov Ther; 2013 Aug; 7(4):137-43. PubMed ID: 24071575 [TBL] [Abstract][Full Text] [Related]
17. Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma. Ishikawa T World J Gastroenterol; 2013 Oct; 19(37):6127-30. PubMed ID: 24115808 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic advances for patients with intermediate hepatocellular carcinoma. Sun JY; Yin T; Zhang XY; Lu XJ J Cell Physiol; 2019 Aug; 234(8):12116-12121. PubMed ID: 30648254 [TBL] [Abstract][Full Text] [Related]
19. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905 [TBL] [Abstract][Full Text] [Related]
20. Goals and targets for personalized therapy for HCC. Couri T; Pillai A Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]